Concepedia

Yaman Tayyar

YT

Statistics

Publications

5

Citations

231

H-Index

5

Active since

2021

Affiliations

Griffith University(Current)

The University of Queensland

Queensland University of Technology

Beckman Research Institute

City of Hope

Yaman Tayyar is an author at Griffith University specializing in nanomedicine, infectious diseases, and nanoparticle drug delivery.

ORCID

Publications per year

2021–2024

5

Publications

5

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

Adi Idris, Alicia Davis, Aroon Supramaniam et al. · Molecular Therapy · 2021 · 163 citations · Full text

, , +12

Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection

Aroon Supramaniam, Yaman Tayyar, Daniel Clarke et al. · Journal of Microbiology Immunology and Infection · 2023 · 24 citations · Full text

, , +17

An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.

Adi Idris, Aroon Supramaniam, Yaman Tayyar et al. · Antiviral Research · 2024 · 17 citations · Full text

, , +17

Alpelisib and radiotherapy treatment enhances Alisertib-mediated cervical cancer tumor killing.

Yaman Tayyar, Adi Idris, Josif Vidimce et al. · PubMed · 2021 · 14 citations · Full text

, , +17

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

Adi Idris, Alicia Davis, Aroon Supramaniam et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 13 citations · Full text

, , +12

1–5 of 5